Clinical trial

SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies

NCT01744236

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-04-01

PhasePHASE4

Study timeline

Study start (unknown)2013-04-01Date precision: month

Registry last updated2015-12-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Interventions

LiraglutideDRUG · verified · RxNorm: liraglutide

SitagliptinDRUG · verified · RxNorm: sitagliptin

ExenatideDRUG · verified · RxNorm: exenatide

Liraglutide placeboDRUG

Sitagliptin placeboDRUG

Exenatide placeboDRUG

Sponsors & collaborators

Amsterdam UMC, location VUmclead sponsor

EU FP7: SAFEGUARD consortiumcollaborator

Mapped research locations

AmsterdamNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01744236 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.